Highly Priced Gene Therapies: A Wake-Up Call for Early Price Regulation

Health Care Spending in the United States and Other High-Income Countries

(2018) Irene Papanicolas et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Factors Associated With Increases in US Health Care Spending, 1996-2013

(2017) Joseph L. Dieleman et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

FDA Approval of Tisagenlecleucel

(2017) Peter B. Bach et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The high price of anticancer drugs: origins, implications, barriers, solutions

(2017) Vinay Prasad et al.   Nature Reviews Clinical Oncology

Research and Development Spending to Bring a Single Cancer Drug to Market and Revenues After Approval

(2017) Vinay Prasad et al.   JAMA Internal Medicine

The High Cost of Prescription Drugs in the United States

(2016) Aaron S. Kesselheim et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Innovation in the pharmaceutical industry: New estimates of R&D costs

(2016) Joseph A. DiMasi et al.   JOURNAL OF HEALTH ECONOMICS

Changing R&D models in research-based pharmaceutical companies

(2016) Alexander Schuhmacher et al.   Journal of Translational Medicine

Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond

(2016) Wesley C. Van Voorhis et al.   PLoS Pathogens

An Open Source Business Model for Malaria

(2015) Christine Årdal et al.   PLoS One

Indication-Specific Pricing for Cancer Drugs

(2014) Peter B. Bach   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Toward more specific and transparent research and development costs: The case of seasonal influenza vaccines

(2013) Ayman Chit et al.   VACCINE

Open Source Drug Discovery in Practice: A Case Study

(2012) Christine Årdal et al.   PLoS Neglected Tropical Diseases

The cost of drug development: A systematic review

(2011) Steve Morgan et al.   HEALTH POLICY